Sinomab Announces IND Application of SN1011 for the Treatment of Neuromyelitis Optica Spectrum Disorder Approved by NMPA
HONG KONG, Aug 24, 2022 – […]
SinoMab Announces IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE
Continuously expanding the sco […]